Arteriovenous Malformation (AVM) Prevention
Arteriovenous Malformation (AVM) Prevention
A brain arteriovenous malformation cannot be prevented, and it was not caused by anything the patient did. That is the honest starting point, and it is worth stating before the recommendations, because much of what circulates about living with one is a list of prohibitions that rest on plausibility rather than evidence. What genuinely changes is short: blood pressure, seizure control if seizures occur, follow-up imaging at intervals, and a plan that has been written down. What does not change is longer, and it includes most of the things patients are most often told to give up.
Blood pressure: the one variable worth treating
An AVM is a high-flow shunt, and the pressure driving blood through it is the patient's own arterial pressure. That is the basis for the one recommendation that is not contested: blood pressure should be measured properly and controlled to the target the patient's own physician sets.
Worth being precise about what this does and does not do. It is a reasonable general measure rather than a demonstrated way of preventing an AVM from bleeding — no trial has shown that lowering pressure reduces haemorrhage from a malformation. But raised pressure is a vascular risk in its own right, and a patient with an AVM has a stronger reason than most to have it controlled well.
Measurement matters more than the reading taken in a clinic. Home readings over a week, taken at the same times each day, give a better picture than a single value recorded in a waiting room, and they are what a physician should be shown. Very high readings — a systolic pressure persistently above about 180, or a diastolic above about 120, with symptoms — are treated as urgent rather than as a matter for the next appointment.
Seizures: the part that actually restricts daily life
When seizures are part of the picture, they are treated with anticonvulsant medication, and most patients become seizure-free on it. The medication is usually taken for years rather than weeks, and stopping it is a decision made with a specialist rather than one taken when a patient feels well.
The practical restrictions are the ones patients find hardest, and they are worth spelling out in advance because they are not negotiable in most countries. Driving is suspended until seizures have been controlled for a defined period, which varies by jurisdiction. Working at height, working with unguarded machinery, swimming alone and similar activities are usually restricted on the same principle.
What is worth saying alongside that: a seizure is not a warning of an imminent bleed, and a patient who is seizure-free on medication is not living under a countdown. The two mechanisms are separate, and conflating them is the most common reason a patient with an AVM restricts far more of their life than the evidence supports.
Activity: what does not need to stop
This is the section most patients want, and the answer is longer on what can continue than on what cannot. Ordinary exercise, including exertion, is not prohibited on the basis of an unruptured malformation. Neither is flying, sexual activity, a demanding job, or a period of stress — none of these has an established association with bleeding from an AVM.
Two categories do warrant discussion rather than reassurance. Contact sport and activities carrying a real risk of a significant head impact are worth discussing individually, not because an impact has been shown to rupture a malformation but because the consequence of one would be more serious in a patient who has one. Anticoagulant and antiplatelet medication, when it is needed for another condition, is a decision to make with a specialist rather than an automatic contraindication.
The general principle for everything else is that a restriction should have a reason. Patients are frequently handed long lists of things to avoid, and the lists tend to grow rather than shrink. Asking what evidence each item rests on is a reasonable question, and a specialist who cannot give an answer for an item should be willing to withdraw it.
Pregnancy, and decisions made in advance
Pregnancy is the question patients most want a rule for, and it is the one where a rule would be wrong. The haemodynamic changes of pregnancy — increased blood volume, increased cardiac output — are real, and whether they materially alter the risk from a malformation is not settled in the way a guideline would require.
What is settled is how the decision is made: individually, on the lesion and the patient, and in advance rather than during a pregnancy. A woman with a known AVM who is planning a pregnancy should discuss it with a neurovascular specialist and with her obstetrician, and the discussion should end in a written plan rather than in a general impression.
The plan usually covers three things: whether the malformation should be treated before pregnancy rather than watched through it; what mode of delivery is recommended, since the pushing stage of a second stage is the part that has been debated; and what happens if a headache or a neurological change occurs during the pregnancy, which should be assessed rather than attributed to the pregnancy.
What to tell the family
Families usually want to know two things: whether they caused it, and whether they are at risk. The answer to the first is no, and it is worth saying to the whole family rather than to the patient alone. The answer to the second is that for a sporadic malformation — one lesion, one person, no family history — relatives are not at increased risk and screening is not advised.
The exception is hereditary haemorrhagic telangiectasia, and the clues are specific enough for a family to recognise them: more than one malformation in one person, a first-degree relative with a known brain AVM, recurrent nosebleeds beginning in childhood, and small red telangiectases on the lips, tongue or fingertips. Where any of those is present, screening is offered rather than assumed.
The other thing worth telling a family is what to do. A family who knows what a bleed looks like, and who will call emergency services rather than drive, is more useful than a family who has been given a list of things to forbid. That is a short conversation and it is worth having once, out loud.
A plan worth writing down
The output of this page should be a short document rather than an impression. Four lines cover it: what the malformation is and what grade it falls into; whether the decision is to treat or to observe, and on what reasoning; what imaging is due and when; and what would change the plan — a seizure, a new deficit, a headache of a kind that needs same-day assessment.
That fourth line is the one most often missing, and it is the one that matters in practice. A patient who knows exactly which symptom means call an ambulance, and which means mention it at the next appointment, is safer than a patient who has been told to be careful. It also stops the common pattern of a family presenting late because they were not sure whether it counted.
Reviews for international patients are returned by a neurovascular specialist as a written opinion within about 48 hours of complete records arriving, and the opinion is written to be shared with the patient's own physician at home. Where the plan is observation, the useful output is the interval and the trigger; where it is treatment, it is the sequence and what each stage is for.